SymSense AI Join waitlist

AI-assisted autoimmune insights that shorten time to confident diagnosis safely.

Transparent reasoning. Intelligent test prioritization. Built for clinicians and patients who want clarity without the noise.

Get early access See how it works
24/7
available guidance
100%
transparency of reasoning
3
clear outcome states
Live demo preview
Status: Ready for assessment
Likely RA, seropositive
Confidence 93%. Priority tests: X-ray hands, TB and hepatitis screening.
Sjögren suspicion
Confidence 55%. Pending Anti-Ro, Anti-La, Schirmer test.
No autoimmune evidence
Very low likelihood. Reassurance. No further testing suggested now.
See more examples

What makes SymSense different

Designed with clinical reality in mind. Our system ranks tests by urgency, explains recommendations in plain language, and flags red alerts that cannot wait.

Intelligent test prioritization

Urgent, important, supportive. Clear tiers so time and budget go where they matter most.

Transparent reasoning

Each suggestion includes the why. No black box. Evidence and criteria are shown.

Red flag escalation

Pulmonary-renal patterns, MAS, CNS lupus and other emergencies are highlighted for immediate action.

False positive prevention

Avoid repeat or low-yield testing when there is no autoimmune evidence.

Progression-aware

Temporal patterns of flares and remissions inform both risk and follow up.

Clear outcomes

Final diagnosis. Provisional diagnosis. More data needed. Simple next steps every time.

How it works

Step 1

Collect the right information

Symptoms, history, labs and images when available. You control what you share.

Step 2

Analyze and explain

AI builds an evidence profile, ranks tests by value and explains why they matter.

Step 3

Guide next steps

Clear outcomes with urgency levels and referral guidance for appropriate care.

Realistic output examples

Illustrative cases that show how SymSense communicates likelihood, urgency and suggested tests. These are examples, not medical advice.

Seropositive rheumatoid arthritis

Confidence 93%. Key evidence: RF+, ACPA+, joint swelling. Urgency: Soon. Baseline X-ray, CRP and ESR recommended.

Primary Sjögren assessment

Confidence 55%. Pending: Anti-Ro, Anti-La, Schirmer, salivary flow. Urgency: Routine.

No autoimmune evidence

Very low likelihood. Alternative causes considered. No extra testing suggested without new findings.

ANCA-associated vasculitis alert

Emergency signals: Hemoptysis with renal changes. Urgency: Immediate. ANCA, anti-GBM, chest imaging and urinalysis.

Systemic sclerosis with ILD concern

Confidence 58%. HRCT and PFTs recommended. Antibody panel including Anti-Scl-70 or centromere.

Mixed connective tissue disease

Overlap features across systems. Check Anti-RNP, CK, aldolase and echo for PASP.

Privacy and safety by design

  • Data control stays with you. Encryption in transit and at rest.
  • Designed for HIPAA-aligned workflows and secure access.
  • Strict separation of consumer marketing data and any clinical records.
  • Clear medical disclaimers and escalation rules for emergencies.

Important medical disclaimer

SymSense provides clinical decision support. It does not replace professional judgment. Always consult a qualified clinician for diagnosis and treatment. Emergencies require immediate in-person care.

Be first to know

Join the early access list and get product updates.

By joining you agree to receive product emails. No spam. Unsubscribe anytime.